Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now later-stage tilt small index

Burn Scar: later-stage trial registry

3 of 5 indexed Burn Scar trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Burn Scar: 5 US clinical trials tracked, 3 recruiting.

Burn Scar is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Medstar Health Research Institute, running 3 of these trials.

Enrollment posture brief

Registry condition burn-scar

OPEN 3 | RECR 60% | LATE 2 | EARLY 1 | RANK #3391 | SPON 3

Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Burn Scar (this)60%
Open-enrollment share among volume-matched conditions near Burn Scar

Burn Scar lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Burn Scar on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Burn Scar is recruiting above its size-band peers.

    3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Burn Scar research.

    Medstar Health Research Institute accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Most Burn Scar trials plan to enrol fewer than 100 people.

    Median target enrolment is 44 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.

  4. Burn Scar research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 31Phase 41

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 1
Phase 4 1

Named interventions

Most-linked intervention names on Burn Scar records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Fractional CO2 Laser Procedure
1 trials
Bimatoprost Drug
1 trials
Remimazolam besylate Drug
1 trials
Famotidine and 4% topical cromolyn sodium Combination
1 trials
Propofol Drug
1 trials
Saline Drug
1 trials
Placebo Other
1 trials

US sites by state

Facility locations filed on Burn Scar trials. A trial with sites in several states counts in each.

Texas 1 trials
South Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Burn Scar page

5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Burn Scar condition card totals 5 registered trials; most-linked intervention Fractional CO2 Laser; top US site state District of Columbia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.